Macquarie Group’s Rocket Pharmaceuticals RCKT Stock Holding History

Macquarie Group’s Portfolio RCKT Stock Details RCKT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-58,000	Closed	-$189K	–	1356
2025 Q3	$189K	Hold	58,000	–	–	﹤0.01%	1491
2025 Q2	$142K	Hold	58,000	–	–	﹤0.01%	1559
2025 Q1	$387K	Hold	58,000	–	–	﹤0.01%	1504
2024 Q4	$729K	Hold	58,000	–	–	﹤0.01%	1395
2024 Q3	$1.07M	Hold	58,000	–	–	﹤0.01%	1364
2024 Q2	$1.25M	Hold	58,000	–	–	﹤0.01%	1335
2024 Q1	$1.56M	Hold	58,000	–	–	﹤0.01%	1292
2023 Q4	$1.74M	Hold	58,000	–	–	﹤0.01%	1264
2023 Q3	$1.19M	Hold	58,000	–	–	﹤0.01%	1306
2023 Q2	$1.15M	Hold	58,000	–	–	﹤0.01%	1333
2023 Q1	$994K	Hold	58,000	–	–	﹤0.01%	1361
2022 Q4	$1.14M	Sell	58,000 -317	-0.5%	-$5.84K	﹤0.01%	1375
2022 Q3	$940K	Sell	58,317 -581	-1%	-$9.07K	﹤0.01%	1431
2022 Q2	$810K	Hold	58,898	–	–	﹤0.01%	1529
2022 Q1	$934K	Hold	58,898	–	–	﹤0.01%	1559
2021 Q4	$1.29M	Hold	58,898	–	–	﹤0.01%	1504
2021 Q3	$1.76M	Hold	58,898	–	–	﹤0.01%	1419
2021 Q2	$2.61M	Hold	58,898	–	–	﹤0.01%	1334
2021 Q1	$2.61M	Sell	58,898 -276	-0.5%	-$15.2K	﹤0.01%	1099
2020 Q4	$3.25M	Hold	59,174	–	–	﹤0.01%	971
2020 Q3	$1.35M	Hold	59,174	–	–	﹤0.01%	1163
2020 Q2	$1.24M	Buy	59,174 +1,174	+2%	+$21.2K	﹤0.01%	1144
2020 Q1	$809K	Hold	58,000	–	–	﹤0.01%	1153
2019 Q4	$1.32M	Hold	58,000	–	–	﹤0.01%	1166
2019 Q3	$676K	Hold	58,000	–	–	﹤0.01%	1318
2019 Q2	$870K	Buy	58,000 +3,000	+5%	+$52.4K	﹤0.01%	1251
2019 Q1	$965K	Buy	55,000 +35,000	+175%	+$553K	﹤0.01%	1195
2018 Q4	$296K	Buy	+20,000	New	+$332K	﹤0.01%	1367

Other funds holding RCKT

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

SCM

Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return

MAM

Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return

Newtyn Management New York $801M AUM 23.14% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Macquarie Group's RCKT Position: Q4 2025 in Review

Macquarie Group sold out of Rocket Pharmaceuticals (RCKT) in Q4 2025, closing a stake of 58,000 shares — an estimated $189K sold.

Macquarie Group first reported a position in RCKT in Q4 2018 and held it in 28 quarters. The position peaked at $3.25M in Q4 2020. 186 funds tracked by Wall St. Rank hold RCKT as of Q4 2025.

Macquarie Group reported no remaining Rocket Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
Macquarie Group sold 58,000 Rocket Pharmaceuticals shares in Q4 2025, an estimated $189K.
Macquarie Group first reported a position in Rocket Pharmaceuticals in Q4 2018 and held it in 28 quarters.
Macquarie Group's Rocket Pharmaceuticals position peaked at $3.25M in Q4 2020.
186 funds tracked by Wall St. Rank held Rocket Pharmaceuticals as of Q4 2025.

Based on Macquarie Group's 13F filing for Q4 2025, filed 13 Feb 2026.